|




| |
WELCOME TO New Jersey HIV
|
NJ HIV and UMDNJ
In November, 2003 the UMDNJ-Robert
Wood Johnson Medical School, Department of Pathology &
Laboratory Medicine was first awarded a grant
under the auspices of the New Jersey Department of Health and Senior Services - Division of HIV/AIDS Services to establish clinical laboratory licensure
and oversight for HIV rapid testing support at multiple sites throughout New
Jersey.
This website serves as the information conduit to allow us
to provide critical information to these sites.
|

|
|
|
COLLABORATION ANNOUNCED
We are pleased to share with you an exciting new collaboration
between the New Jersey Department of Health and Senior Services,
Division of HIV/AIDS Services (DHAS) and GREATER THAN AIDS, a new
national mobilization effort launched last year. The Kaiser Family
Foundation – a leader in health communications – provides strategic
direction and day to day management as well as oversees the production
of the media campaign. The Black AIDS Institute is a founding partner,
providing leadership and technical assistance.
The primary message is about the power of individuals
acting together to achieve a greater goal – in this case, reducing the
spread of HIV. By stressing unit, hope and empowerment, GREATER THAN
AIDS seeks to inspire each and every one of us – in our relationships,
families, and communities – to do our part to stem HIV/AIDS.
The first-phase of this national campaign –
including outdoor, radio, print and online public service ads-debuted
last fall and included outdoor and radio advertising in New Jersey. The
second-phase will launch in conjunction with National HIV Testing Day in
June 2010. Beginning late summer, GREATER THAN AIDS outdoor ads in New
Jersey (including billboards and transit shelters) will be tagged with
the state’s AIDS hotline (1-800-624-2377) to help connect our citizens
with local services and resources.
We encourage
you to post the GREATER THAN AIDS campaign’s banner ads on your
organization’s website:
www.greaterthanaids.org/banners
NJ HIV PROGRAM
FIRST
PLACE WINNER
ASTHO 2006 Vision Awards

The
Association of
State and Territorial Health Officials
(ASTHO) Vision Awards are presented each year
to honor outstanding state health department programs and initiatives.
The awards signify peer recognition of creative state health programs.
|
Sites
With Rapid Testing is Available
Sites With Rapid-Rapid
Testing Available 
|
|
WHAT IS
RAPID-RAPID HIV TESTING?
Rapid HIV testing utilizes a single rapid testing
device in order to determine whether individual is likely to have
become infected with HIV.
Current regulations require
that an additional confirmatory test, a western blot, an IFA or a
nucleic amplification test be conducted in order to diagnose an
individual as infected with HIV.
Some sites in New Jersey
utilize a second, independent rapid HIV test to verify the initial
rapid HIV result. An individual who is positive on both rapid
HIV tests has less than a .8% probability of not being infected.
At many Counseling and Testing
Sites in New Jersey two positive, but different rapid tests are
sufficient to link an individual immediately into the healthcare
system so that they can meet with a healthcare provider and
begin formulating a plan to address their infection.
|
HIV COST AND REIMBURSEMENT
HRET, the
Hospital, Research
and Education Trust has developed a free online toolkit
for cost and reimbursement issues surrounding HIV
testing and screening that is available at
www.hret.org/hiv-cost. The package includes a downloadable
calculator to assist hospitals, clinics and physicians in
understanding the cost of HIV
testing programs and maximizing reimbursement. The resource was
developed in partnership with
the Centers for Disease Control and Prevention.
Please remember that charging for HIV tests provided to a facility
by the Division of HIV/AIDS IS NOT permitted!
|
|
WHAT
IS RAPID HIV TESTING?
A rapid test for detecting antibody to HIV is
a screening test that produces results in 5 to 30 minutes. Unlike
conventional HIV testing
that utilizes a procedure known as an enzyme immunoassay (EIA),
rapid HIV testing is simpler, but has about equal sensitivity and
specificity in detecting the presence of antibodies to the human
immunodeficiency virus type I or II. As with with traditional
testing, a more specific confirmatory test must also be positive
before concluding that an HIV infection exists.
Even though it is simpler, in New
Jersey clinical laboratory licensure is required to conduct rapid
HIV testing. Our laboratory activities have been continuously accredited by the
College of American Pathologists (CAP)
since their inception in 1985.
|
NJ HIV PROCEDURES &
FORMS
Rapid HIV procedures,
forms and policies are available for your use.
We invite you to review,
copy, print and use our latest procedures, forms and policies! See
POCT Forms
|
|
|
|
|
ANNOUNCEMENTS |
Important: Health Departments (HDs) and Community-Based
Organizations (CBOs) funded by the Centers for Disease Control and
Prevention (CDC) to provide HIV counseling, testing, and referral (CTR)
services are required to collect data
about their HIV prevention
activities. Beginning February 1, 2008 NJ Division of HIV/AIDS (DHAS)-funded CBOs and HDs
are to utilize the new PEMS form which has been in development by the
CDC for some time.
|
|
|
RECENT MEETING:
Annual Coordinators Meeting 4-20-11 - DHSTS Presentations
SAGE Presentation - April2011\
Annual Coordinators Meeting 4-20-11 - NJ HIV Rapid Support Group
REFERENCES:
Centers for Disease Control and Prevention. Revised Recommendations
For HIV Testing of Adults, Adolescents and Pregnant Women in
Health-Care Settings. MMWR 2006:55(RR14):1-1. Available at:
http://www.cdc.gov/mmwr/PDF/rr/rr5514.pdf
Centers for Disease Control and Prevention. Rapid
HIV Antibody Testing During Labor and Delivery for Women of Unknown
HIV Status: A Practical Guide and Model. 2004
http://www.cdc.gov/hiv/Labor&DeliveryRapidTesting.pdf

|
Division of HIV/AIDS February 6, 2008
The link below
provides a PDF copy of the Manual supplied by the CDC
for use with the new HIV Testing Form (released November 2007).
PEMS
FORM MANUAL
The link below provides a PDF copy of the
provider letter sent by Carmine Grasso, M.P.H., M.S.W.,
the Director of Care & Treatment Services - NJ DHAS to all NJ DHAS-funded
HD and CBO providers. The letter includes a Quick Reference Guide
for proper form completion and contact information to obtain a
supply of PEMS forms and the unqiue agency and site numbers
necessary to complete the the three part test form
DHAS
PROVIDER LETTER
Division of HIV/AIDS
(DHAS) is now:
DHSTS
DHAS Presentation Annual Coordinator Meeting 3-05-10
Presenter:
Maureen Wolski |
. |
Robert Wood Johnson Medical School
Pathology and Laboratory Medicine
NJ HIV
Clinical Laboratory
Faculty
|
Faculty
Member |
Education |
Administrative
Position/Interests
|
Academic
Title |
|
Evan
M. Cadoff, M.D
Principal Investigator -
DHAS Program
|
SUNY
at Stony Brook, 1981
|
Acting Chairman, Department of Pathology
& Laboratory Medicine
Co-Director, NJ DHSS Public and Environmental Health Laboratories
|
Professor
of Pathology & Laboratory Medicine
Chief,
Division of Clinical Pathology
|
|
Eugene
G. Martin, Ph.D.
CO-DIRECTOR -
NJ HIV
|
New York
Medical
College,
1981
|
Administrative Director, UDL
Sub-Director, POCT testing
Co-director, all NJ DHAS sites
|
Professor
of Pathology & Laboratory Medicine
Co-Director, Pathology course -
Physicians Assistant Course
|
|
Gratian Salaru, M.D.
Principal Investigator - DAS Program
DIRECTOR (BLD) - DAS sites
|
University of Medicine and Pharmacy,
Timisoara, Romania, 1995 |
Hematopathology, Clinical and Anatomic
Pathology |
Assistant Professor
of
Pathology & Laboratory Medicine |
Parisa Javidian, M.D.
DIRECTOR (BLD) - DHAS sites |
George Washington
University, 1989 |
Clinical and Anatomic Pathology
Director,
all NJ DHAS sites |
Associate Professor
of
Pathology & Laboratory Medicine |
Contact Information
General Inquiries can be directed to the Administrative Offices listed below.
The office hours are 8:30 am - 4:30 pm, Monday-Friday.
- Telephone
- 732-743-3630
|